Felipe Prósper
Impact in
- Hematology top 0.2%
- Multiple Myeloma Research and Treatments
- Genetics top 0.2%
- Mesenchymal stem cell research
Papers in
-
- Pluripotent Stem Cells Research 30
- Epigenetics and DNA Methylation 29
- Hematology 101
- Multiple Myeloma Research and Treatments 43
- Acute Myeloid Leukemia Research 28
- Co-authors
- Xabier Agirre (92 shared papers)Beatriz Pelacho (52 shared papers)Enrique J. Andreu (34 shared papers)José Román‐Gómez (30 shared papers)María J. Blanco‐Prieto (26 shared papers)Edurne San José‐Eneriz (39 shared papers)Catherine M. Verfaillie (20 shared papers)Gloria Abizanda (61 shared papers)
- Journals
- Blood (39 papers)PLoS ONE (12 papers)Leukemia (10 papers)Haematologica (10 papers)British Journal of Haematology (8 papers)
- Partner nations
- SpainUnited StatesGermany
In The Last Decade
Felipe Prósper
376 papers receiving 14.3k citations
Felipe Prósper's Hit Papers
Peers
Comparison fields: 5 of 162
- Hematology 2.6k
- Genetics 2.3k
- Cancer Research 1.9k
- Biomaterials 1.4k
- Molecular Biology 6.0k
Countries citing papers authored by Felipe Prósper
This map shows the geographic impact of Felipe Prósper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Felipe Prósper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Felipe Prósper more than expected).
Fields of papers citing papers by Felipe Prósper
This network shows the impact of papers produced by Felipe Prósper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Felipe Prósper. The network helps show where Felipe Prósper may publish in the future.
Co-authors
The 25 scholars most cited alongside Felipe Prósper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 391 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2 Hit paper breakdown → | 2020 | 1550 |
| 2 | 2009 | 371 | |
| 3 | 2002 | 353 | |
| 4 | Lenalidomide plus Dexamethasone for High-Risk Smoldering Multiple Myeloma Hit paper breakdown → | 2013 | 353 |
| 5 | 2000 | 301 | |
| 6 | 2016 | 251 | |
| 7 | 2009 | 242 | |
| 8 | 1999 | 229 | |
| 9 | 2008 | 173 | |
| 10 | 2008 | 157 | |
| 11 | 2019 | 154 | |
| 12 | 1999 | 147 | |
| 13 | 2019 | 144 | |
| 14 | Lipid nanoparticles for siRNA delivery in cancer treatment Hit paper breakdown → | 2023 | 128 |
| 15 | 1998 | 120 | |
| 16 | 2015 | 118 | |
| 17 | 2016 | 117 | |
| 18 | 2004 | 113 | |
| 19 | 2008 | 111 | |
| 20 | 2016 | 109 |
About Felipe Prósper
Felipe Prósper is a scholar working on Molecular Biology, Hematology, Surgery, Genetics and Oncology, having authored 391 papers that have together received 14.5k indexed citations. Recurring topics across this work include Tissue Engineering and Regenerative Medicine (66 papers), Mesenchymal stem cell research (45 papers), Multiple Myeloma Research and Treatments (43 papers), Electrospun Nanofibers in Biomedical Applications (39 papers), Pluripotent Stem Cells Research (30 papers), Epigenetics and DNA Methylation (29 papers), Acute Myeloid Leukemia Research (28 papers) and CAR-T cell therapy research (21 papers). The work is most often cited by research in Hematology (2.6k citations), Genetics (2.3k citations), Cancer Research (1.9k citations), Biomaterials (1.4k citations) and Molecular Biology (6.0k citations). Felipe Prósper has collaborated with scholars based in Spain, United States and Germany. Frequent co-authors include Xabier Agirre, Beatriz Pelacho, Enrique J. Andreu, José Román‐Gómez, María J. Blanco‐Prieto, Edurne San José‐Eneriz, Catherine M. Verfaillie, Gloria Abizanda, José L. Fernández-Luna and Elisa Garbayo. Their work appears in journals such as Blood, PLoS ONE, Leukemia, Haematologica and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.